Found 60 matching trials
Personalized Neoantigen Peptide Vaccines for Solid Tumors PHASE1 This clinical trial is studying the safety and efficacy of a personalized c...
Show More Location
Horizon Cancer Excellence Center, Bumrungrad International Hospital
Learn More & Join Trial
Individualized Neoantigen Therapy with Unusual Radiotherapy Enhancement (iNATURE) PHASE2 In this study, the investigators provide an individualized tumor neoantigen...
Show More Location
University of Hong Kong-Shenzhen Hospital
Learn More & Join Trial
NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma PHASE1 This research study is studying the drugs called NeoVax (a new type of pers...
Show More Status
Active Not Recruiting
Location
Dana-Farber Cancer Institute
Learn More & Join Trial
Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC PHASE2 The goal of this clinical trial is as follows:(1) Establish a clinical tech...
Show More Location
Second Affiliated Hospital of Wenzhou Medical University
Learn More & Join Trial
Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma PHASE1 The goal of this open-label, single-arm phase I/II clinical trial is to eva...
Show More Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment NA In this study, the investigators provide a combined treatment of personaliz...
Show More Location
First Affiliated Hospital of Nanchang University
Learn More & Join Trial
COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer EARLY_PHASE1 This is an early phase I, single-arm, open-label clinical study designed to...
Show More Location
Biogenea Pharmaeuticals Ltd
Learn More & Join Trial
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors PHASE1 This phase I/II trial tests the safety and tolerability of an experimental ...
Show More Location
Mayo Clinic in Florida
Learn More & Join Trial
A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors PHASE1 A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Effic...
Show More Status
Enrolling By Invitation
Location
Precision NextGen Oncology & Research Center
Learn More & Join Trial
Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors PHASE1 This clinical trial aims to evaluate the safety, immunogenicity, and prelim...
Show More Location
Vejthani Hospital
Learn More & Join Trial